Thirteen Harvard faculty members were elected to the National Academy of Medicine (NAM) this week, including half a dozen whose work has been profiled in Harvard Magazine:
The NAM (formerly the Institute of Medicine) provides authoritative scientific information and advice on issues in health and medicine to policymakers, leaders, and professionals around the globe. Current members elect new members to the organization annually.
Citations accompanying the election of the Harvard faculty members follow.
Dan H. Barouch, ’93, M.D. ’99, Ph.D., Castle professor of medicine, Harvard Medical School (HMS); and director, Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center. For being an international leader in virology and immunology and developing novel vaccines and cure strategies for viruses of global importance, including working on one of the first COVID-19 vaccine candidates, the first Zika virus vaccine, and the first global mosaic HIV-1 vaccine, as well as defining immunotherapeutic HIV-1 cure strategies.
Myles Brown, M.D., Frei professor of medicine, HMS; and director, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute. For his leadership in oncology and endocrinology, whose seminal contributions have fundamentally reformulated the mechanistic understanding of hormone dependence of breast and prostate cancers, enabling the development of new therapies for these diseases.
Yolonda Lorig Colson, M.D., Ph.D., chief of Division of Thoracic Surgery, Massachusetts General Hospita (MGH)l; and Grillo professor of surgery in the field of thoracic surgery, HMS. For contributions to the fields of thoracic surgery, polymer-mediated chemotherapy release, and lymphatic drug delivery, and for leading a national paradigm shift to improve maintenance of